Copyright Reports & Markets. All rights reserved.

Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Malaria
      • 1.4.3 Ebola
      • 1.4.4 Dengue
      • 1.4.5 Chagas
      • 1.4.6 Leishmaniasis
      • 1.4.7 Other
    • 1.5 Market by Application
      • 1.5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2019-2025)
      • 1.5.2 Drugs
      • 1.5.3 Vaccines
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size
    • 2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
      • 2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2019-2025)
      • 2.2.2 Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by by Players
      • 3.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by by Players (2014-2019)
      • 3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
    • 3.3 Key Players Neglected Tropical Diseases Drugs and Vaccine Product/Solution/Service
    • 3.4 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2014-2019)
    • 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 5.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in North America
    • 5.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 5.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    6 Europe

    • 6.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 6.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Europe
    • 6.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 6.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    7 China

    • 7.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 7.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in China
    • 7.3 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 7.4 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    8 Japan

    • 8.1 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 8.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Japan
    • 8.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 8.4 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 9.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Southeast Asia
    • 9.3 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 9.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    10 India

    • 10.1 India Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 10.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in India
    • 10.3 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 10.4 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size (2014-2019)
    • 11.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Central & South America
    • 11.3 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
    • 11.4 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

    12 International Players Profiles

    • 12.1 Artecef BV
      • 12.1.1 Artecef BV Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019))
      • 12.1.5 Artecef BV Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 AstraZeneca
      • 12.3.1 AstraZeneca Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.3.5 AstraZeneca Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Sanofi-Aventis
      • 12.5.1 Sanofi-Aventis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.5.5 Sanofi-Aventis Recent Development
    • 12.6 Ranbaxy Labs
      • 12.6.1 Ranbaxy Labs Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.6.5 Ranbaxy Labs Recent Development
    • 12.7 Lupin
      • 12.7.1 Lupin Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.7.5 Lupin Recent Development
    • 12.8 Macleods Pharmaceuticals
      • 12.8.1 Macleods Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.8.5 Macleods Pharmaceuticals Recent Development
    • 12.9 Cipla
      • 12.9.1 Cipla Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.9.5 Cipla Recent Development
    • 12.10 Romark Laboratories
      • 12.10.1 Romark Laboratories Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Neglected Tropical Diseases Drugs and Vaccine Introduction
      • 12.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2014-2019)
      • 12.10.5 Romark Laboratories Recent Development
    • 12.11 Toyama Chemica

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Neglected Tropical Diseases Drugs and Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neglected Tropical Diseases Drugs and Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Artecef BV
      GlaxoSmithKline
      AstraZeneca
      Novartis
      Sanofi-Aventis
      Ranbaxy Labs
      Lupin
      Macleods Pharmaceuticals
      Cipla
      Romark Laboratories
      Toyama Chemica

      Market segment by Type, the product can be split into
      Malaria
      Ebola
      Dengue
      Chagas
      Leishmaniasis
      Other

      Market segment by Application, split into
      Drugs
      Vaccines

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Neglected Tropical Diseases Drugs and Vaccine status, future forecast, growth opportunity, key market and key players.
      To present the Neglected Tropical Diseases Drugs and Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Neglected Tropical Diseases Drugs and Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now